Mayo Clinic Partners with Microsoft and Cerebras on Radiology and Genomics Foundation Models

Mayo Clinic has announced collaborations with Microsoft Research and Cerebras Systems to explore the potential of generative artificial intelligence (AI) …

Continue ›››

Longevity Company Rubedo Announces Phase 1 Trials for GPX4 Modulator Targeting Aging Cells and Surrounding Tissues

Rubedo Life Sciences has unveiled its clinical development plans for RLS-1496, a first-in-class GPX4 modulator, during the 12th Annual Dermatology …

Continue ›››

Swiss Researchers Advance Spatial Proteomics with AI-Powered Virtual Tissue Foundation Model

Researchers from École Polytechnique Fédérale de Lausanne (EPFL) and ETH Zurich, in collaboration with the University Hospital Zurich and the University …

Continue ›››

Baker Lab: Neutralizing Snake Venom with AI-Designed Miniproteins

Researchers from the Baker Lab at the University of Washington, in collaboration with the Digital Biotechnology Lab at the Technical …

Continue ›››

Recursion and Faro Health Partner to Reimagine Clinical Trial Design with AI

Faro Health has partnered with Recursion to streamline clinical protocol design using Faro's AI-driven platform.

Continue ›››

Servier, Google Cloud Extend Partnership to Accelerate Drug Development with AI

Servier, an international pharmaceutical group, and Google Cloud have announced a five-year extension of their collaboration to integrate AI technologies …

Continue ›››

Lupa Raises $4M to Modernize Veterinary Care with AI

Lupa, a London-based startup developing an AI-powered veterinary operating system, has raised $4 million in seed funding from investors including …

Continue ›››

Proscia Grows with 2.4 Million Patients Diagnosed via AI Pathology Platform

Proscia, a company specializing in AI-enabled pathology solutions, reported significant growth in 2024, driven by an increasing demand for enterprise …

Continue ›››

AI-Driven Analysis Optimizes Clinical Strategy for A28’s Liver Cancer Peptide Therapy

A28 Therapeutics, a clinical-stage biopharmaceutical company, and GATC Health Corp, a developer of AI-driven drug discovery tools, have announced the …

Continue ›››

Umoja Secures $100M For In Vivo CAR-T Therapies

Umoja Biopharma has secured $100 million in an oversubscribed Series C funding round. Based in Seattle, Washington, and founded in …

Continue ›››

Eli Lilly Acquires Scorpion Therapeutics' Oncology Program for $2.5 Billion

Eli Lilly announced the acquisition of Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program for up to $2.5 billion, expanding its oncology …

Continue ›››

Vevo Therapeutics Plans to Open Source 100M Single-Cell Atlas for Drug Discovery

Vevo Therapeutics has announced plans to open source its Tahoe-100M dataset, described as the world's largest single-cell transcriptomic atlas of …

Continue ›››